After therapy with EMPA and GLI, the effects of the adipocytokines from pericardial fat tissues on the IK decreasing and ICa,L overload were attenuated, which might contribute to reducing vulnerability to cardiac arrhythmias in MS with glucose-lowering drug therapy. Here, GLI1 is linked to cardiac arrhythmia.